Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness.
- 1 January 1985
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 16 (1) , 1-4
- https://doi.org/10.1161/01.str.16.1.1
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic PatientsNew England Journal of Medicine, 1983
- A Controlled Comparison of Aspirin and Oral Anticoagulants in Prevention of Death after Myocardial InfarctionNew England Journal of Medicine, 1982
- Inhibition of Prostacyclin and Platelet Thromboxane A2after Low-Dose AspirinNew England Journal of Medicine, 1981
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980
- Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose AspirinNew England Journal of Medicine, 1979
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978
- The Hazards of Aspirin plus HeparinNew England Journal of Medicine, 1978
- Aspirin in coronary heart diseaseJournal of Chronic Diseases, 1976
- Novel prostaglandin derivative formed from arachidonic acid by rat stomach homogenatesBiochemistry, 1971